BioSpace News Archive

Adial Pharmaceuticals, Inc., issued the following letter to its shareholders from the Company’s CEO, William Stilley.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced top-line results from the Phase 3 RELEASE MSS1 trial ( NCT04657666 ) evaluating nabiximols oromucosal spray (JZP378, or Sativex ® , ex-U.S.) on clinical measures of spasticity in individuals with multiple sclerosis (MS).

Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that biomarker studies that have identified genes that are differentially expressed between healthy individuals and those with Friedreich’s ataxia will be featured in an oral presentation at the upcoming Gordon Research Conference on Mitochondria and Chloroplasts.

Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Discovery Simulator, a new software designed for scientists working in small molecule drug discovery and translational research.

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new data from a follow-up analysis of a subset of participants from the pivotal Phase 3 study (PROTECT) of the Company’s 3-antigen prophylactic hepatitis B (HBV) vaccine.

Applied BioMath (www.appliedbiomath.com), the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate and de-risk therapeutic research and development (R&D), is proud to welcome Bruce Gomes , PhD, as Executive Director of Business Development & Scientific Collaborations.

NeuroMetrix, Inc. announced the appointment of Bradley M. Fluegel to its Board of Directors, effective as of July 1, 2022.

ResMed announced the promotion of Lucile Blaise to President of Sleep & Respiratory Care, effective July 1, 2022.

Partnership will transform ASC cardiovascular care delivery and expand patient access.

NYU Langone Fertility Center, a member of Inception Fertility’s network of clinical practices, in conjunction with NYU Grossman School of Medicine, released the largest U.S. report of elective fertility preservation outcomes to date.